Currently, SIRT5 and 6 have not been investigated in gastric cancer, but have been shown to be involved in other cancers, such as breast cancer, lung cancer, hepatocellular carcinoma, head and neck squamous cell carcinoma, and ovarian cancer [45–50]. Here, SIRT5 is linked to breast carcinoma.